N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link...

N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link...

[Anonymous].  2011.  N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link.... The Journal of pharmacology and experimental therapeutics. 336(1):165-77.

Bi-directional screening for tuberculosis and diabetes: a systematic review.

Cryotherapy to treat persistent muscle weakness after joint injury.

Gist reasoning training in cognitively normal seniors.

Alcohol consumption among men and women with tuberculosis in Tomsk, Russia.

Partial carpal arthrodesis in a 2-year-old alpaca.

Hydrothermal synthesis and extended structure of poly aqua(μ5-ethylenediaminetetraacetato)dizinc(II) .

Transcranial magnetic stimulation and volitional quadriceps activation.

A screen-printed microband glucose biosensor system for real-time monitoring of toxicity in cell culture.

Expanding access to telespeech in clinical settings: inroads and challenges.